The 24 Hour Lung Function Time Profile of Olodaterol Once Daily Versus Placebo and Tiotropium in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Abstract

Background: Olodaterol is a once-daily long-acting 2-agonist being investigated for the treatment of chronic obstructive pulmonary disease, with 24 hour bronchodilator activity.